Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00384774
Status:
COMPLETED
Last Update Posted:
2019-12-02
First Post:
2006-10-04
Brief Title:
A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company